For Research Use Only. This product is supplied exclusively for laboratory research and is not intended for human or veterinary use.
Ipamorelin Research Peptide
Ipamoreline (development code NNC 26-0161) is a synthetic pentapeptide classified as a growth-hormone secretagogue receptor agonist. ZENTRA supplies it as high-purity lyophilised research material in 5mg and 10mg formats.
Its five-residue structure includes non-standard and D-amino-acid residues: Aib-His-D-2-Nal-D-Phe-Lys-NH2. It is investigated through the ghrelin/growth-hormone-secretagogue receptor pathway, which is distinct from the GHRH-receptor pathway studied with CJC-1295 analogues.
Technical Specifications
| Product | Ipamoreline |
|---|---|
| Development code | NNC 26-0161 |
| Peptide length | 5 residues |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Molecular formula | C38H49N9O5 |
| Molecular weight | Approximately 711.9 g/mol |
| CAS number | 170851-70-4 |
| Purity | Above 99% by third-party HPLC testing |
| Physical form | White lyophilised powder |
| Available formats | 5mg and 10mg |
| Intended use | Laboratory research and analytical use only |
Independent Batch Testing
Every current ZENTRA Ipamoreline batch is independently tested and records an HPLC purity result above 99%. The batch number on the product label can be checked against the corresponding third-party report in our Batch Verification and COA Centre. Researchers should consult the individual report for the exact analytical methods, result and testing date for their supplied batch.
Ipamoreline Research Context
The original pharmacology work described ipamoreline as a selective growth-hormone secretagogue and examined GH release in cell and animal models. A later experimental study assessed endocrine responses in healthy volunteers, while other preclinical work investigated ghrelin-receptor-related gastrointestinal signalling in rodents.
These studies do not establish an approved use, long-term safety or body-composition outcome. Ipamoreline is not growth hormone itself, and its receptor pathway should not be confused with the GHRH analogues CJC-1295 or modified GRF(1-29).
Storage and Handling
For long-term storage, keep unopened lyophilised material at approximately -20°C. For short-term laboratory storage, maintain at 2-8°C. Protect the vial from light, moisture and repeated temperature changes. Use appropriate laboratory handling procedures and consult your institutional protocol before preparing research solutions.
Ipamoreline Research FAQs
What is Ipamoreline?
Ipamoreline is a synthetic five-residue growth-hormone secretagogue studied as an agonist of the ghrelin/GHS receptor.
Is Ipamoreline a GHRH analogue?
No. It acts through the growth-hormone-secretagogue/ghrelin-receptor pathway. CJC-1295 analogues act through the GHRH receptor.
Which sizes are available?
This product is available as 5mg and 10mg of lyophilised research material.
What evidence exists?
The evidence includes receptor, cell, animal and limited human experimental work. It does not establish an approved therapeutic use or long-term safety profile.
How is purity verified?
Every current batch is independently HPLC tested above 99% purity with online batch-level COA verification.
Is this product intended for human or veterinary use?
No. It is supplied strictly for laboratory research and analytical purposes.
Selected Primary Research
- Ipamorelin, the first selective growth-hormone secretagogue.
- Experimental endocrine responses to Ipamorelin.
- Ipamorelin as a ghrelin-receptor agonist in a rodent model.
Research Resources
- CJC-1295 without DAC
- CJC-1295 with DAC
- Batch Verification and COAs
- Research Peptide Storage Guide
- Lyophilised Research Material Preparation Guide
- Browse All Research Peptides
For research use only. Not for human or veterinary use.
